It may take twice daily applications for 2 months or more before evidence of hair growth can be expected.

Regaine | Hair Loss Treatment | LloydsPharmacy

The patient should stop using Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam and see a doctor if hypotension is detected or if the patient is experiencing chest pain, rapid heartbeat, faintness or dizziness, sudden unexplained weight gain, swollen hands or feet or persistent redness or irritation of the scalp or other unexpected new symptoms occur (see section 4. Hair loss in women is more common than you may think with 40% of women have visible hair loss by the time they are age 40. Seek advice before using if you are pregnant, planning to become pregnant, breastfeeding or if you suffer from allergies.Therefore, hormonally mediated tumour promotion by minoxidil does not represent a carcinogenic risk to humans. Wash your hands after applying Regaine to avoid accidentally getting it on other areas of skin - this could cause hair growth where you don't want it. The safety of topical minoxidil from clinical trial data is based on data from 7 placebo-controlled randomised clinical trials in adults evaluating either 2% or 5% minoxidil solution, and two placebo-controlled randomised clinical trials in adults evaluating a 5% foam formulation. Regaine for Women Regular Strength Twin Pack helps to prevent further hereditary hair loss in women and works to regrow hair that has previously been lost. The safety and effectiveness of Regaine for Men Extra Strength Scalp Solution 5% w/v Cutaneous Solution in children and adolescents below the age of 18 years or adults over 65 years has not been established.

TAKE CONTROL OF YOUR HAIR LOSS | Regaine UK

The primary efficacy endpoints were a) mean change in non-vellus hair count within the target region between Baseline and Week 16, as determined by validated computer-assisted dot-mapping technique; and b) subject rating of treatment benefit via use of global photographs of the vertex region, assessed as an overall improvement from baseline, collected on a subject questionnaire. Clinical Trials have not investigated the efficacy of Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam beyond 16 weeks. Topical minoxidil is only indicated for the treatment of alopecia androgenetica and should not be used in other types of hair loss for example when there is no family history of hair loss, hair loss is sudden and/or patchy, hair loss is due to childbirth, or the reason for hair loss is unknown. Regaine is for the treatment of hereditary hair loss and works best in men who have been losing their hair for a short period of time. Based upon these photographic data, around 60% of the patients experienced an increased scalp coverage after 48 weeks treatment with Regaine for Men Extra Strength Scalp Solution 5% w/v Cutaneous Solution as defined by re-growth of hair; compared with around 23% at an average for those who received vehicle alone.If hair regrowth occurs, twice daily applications of Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam are necessary for continued hair growth. Avoid exposure of the container and contents to naked flames should be avoided during use, storage and disposal. The safety and effectiveness of Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam in children and adolescents below the age of 18 years or adults over 49 years old has not been established.